Amyloidosis Research This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials
• Forums

Clinical validation of the PrecivityAD2 blood test: A mass spectrometry-based test with algorithm combining %p-tau217 and A β42/40 ratio to identify presence of brain amyloid
DISCUSSION: The PrecivityAD2 blood test showed strong clinical validity, with excellent agreement with brain amyloidosis by PET.PMID:38491912 | DOI:10.1002/alz.13764 (Source: The Journal of Alzheimers Association)
Source: The Journal of Alzheimers Association - March 16, 2024 Category: Psychiatry Authors: Matthew R Meyer Kristopher M Kirmess Stephanie Eastwood Traci L Wente-Roth Faith Irvin Mary S Holubasch Venky Venkatesh Ilana Fogelman Mark Monane Lucy Hanna Gil D Rabinovici Barry A Siegel Rachel A Whitmer Charles Apgar Randall J Bateman David M Holtzman Source Type: research